Efficacy of pharmacological and interventional treatment for resistant hypertension: a network meta-analysis

Z Tian, C Vollmer Barbosa, H Lang… - Cardiovascular …, 2024 - academic.oup.com
Aims Resistant hypertension is associated with a high risk of cardiovascular disease,
chronic kidney disease, and mortality. Yet, its management is challenging. This study aims to …

[HTML][HTML] Clinical efficacy of spironolactone for resistant hypertension: a meta analysis from randomized controlled clinical trials

H Guo, Q Xiao - International journal of clinical and experimental …, 2015 - ncbi.nlm.nih.gov
Objectives: This study sought to determine the current effectiveness and safety of
spironolactone for resistant hypertension. Methods: Pubmed, EMBASE and Cochrane …

Efficacy and safety of spironolactone in patients with resistant hypertension: a meta-analysis of randomised controlled trials

C Wang, B Xiong, J Huang - Heart, Lung and Circulation, 2016 - Elsevier
Background The treatment of resistant hypertension (RH) is challenging. Several
observational studies have suggested that the addition of spironolactone to triple-drug …

Identifying patients with resistant hypertension and options for clinical management

TT Cheung, BMY Cheung - Future Cardiology, 2012 - search.proquest.com
In addition to the increasing prevalence of hypertension, the number of patients with
treatment-resistant hypertension is also rising. It is important to identify these patients in …

How effective is spironolactone for treating resistant hypertension?

C Lyon, B Utter, K DeSanto - 2019 - mospace.umsystem.edu
Q: How effective is spironolactone for treating resistant hypertension? EVIDENCE-BASED
ANSWER: VERY EFFECTIVE. Spironolactone reduces systolic blood pressure (SPB) by 11 …

A meta-analysis of add-on use of spironolactone in patients with resistant hypertension

D Zhao, H Liu, P Dong, J Zhao - International journal of cardiology, 2017 - Elsevier
Objective The efficacy of add-on use of spironolactone in patients with resistant
hypertension has been investigated in several small studies. We performed this meta …

Spironolactone versus clonidine as a fourth-drug therapy for resistant hypertension: the ReHOT randomized study (Resistant Hypertension Optimal Treatment)

EM Krieger, LF Drager, DMA Giorgi, AC Pereira… - …, 2018 - Am Heart Assoc
The aim of this study is to compare spironolactone versus clonidine as the fourth drug in
patients with resistant hypertension in a multicenter, randomized trial. Medical therapy …

Identifying patients with resistant hypertension and options for clinical management

T Tsang Cheung, B Man Yung Cheung - Future Cardiology, 2012 - Taylor & Francis
In addition to the increasing prevalence of hypertension, the number of patients with
treatment-resistant hypertension is also rising. It is important to identify these patients in …

Global prevalence of resistant hypertension: a meta-analysis of data from 3.2 million patients

JJ Noubiap, JR Nansseu, UF Nyaga, PS Sime… - Heart, 2019 - heart.bmj.com
Objective We conducted the first systematic review and meta-analysis to estimate the
specific prevalence of apparent treatment-resistant, pseudo-resistant and true-resistant …

Hypertension Canada's 2020 evidence review and guidelines for the management of resistant hypertension

S Hiremath, R Sapir-Pichhadze, M Nakhla… - Canadian Journal of …, 2020 - Elsevier
Abstract We present Hypertension Canada's inaugural evidence-based recommendations
for the diagnosis and management of resistant hypertension. Hypertension is present in …